Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Lexagene Holdings Inc > The Company is extremely undervalued
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(159)
•••
Comment by TanzaniteMotherLodeon Apr 26, 2020 3:31pm
177 Views
Post# 30955259

RE:The Company is extremely undervalued

RE:The Company is extremely undervalued"The company is extremely undervalued" is an understatement.  On MEET the Press the guest was Dr. Michael Osterholm, Director of the Center for Infectous Disease Research and Policy and Author of the "Deadliest Enemy:  Our War Against Killer Germs"  said during his interview...........three major problems with testing right now........1 don't have reagents (the whole world is looking for them....LXG makes their own and has no shortage)........2 we have the wild wild west with testing right now and the FDA has all but given up its oversight responsibility with testing and as a result many of them are nothing short of a disaster - they got into that place cause the CDC had a problem and they just opened up the gate - and that resulted in a lot of bad tests on the market........3 ....that tests just don't perform well in low populations.  What we need is a major new initiative on testing that gets away from how many people get tested.....

Folks LXG is the answer in testing what the world needs.............they are definitely going to get fast tracted to commercial production...... 




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities